Skip to content
The Policy VaultThe Policy Vault

EpidiolexMedical Mutual

Dravet Syndrome (Severe Myoclonic Epilepsy in Infancy)

Initial criteria

  • Patient is age ≥ 1 year
  • Patient has tried or is concomitantly receiving one antiepileptic drug used for Dravet Syndrome OR patient has tried or is concomitantly receiving at least two other antiseizure medications
  • Medication is prescribed by or in consultation with a neurologist

Reauthorization criteria

  • Patient is currently receiving Epidiolex and is responding to therapy (e.g., reduced seizure activity, frequency, and/or duration) as determined by the prescriber

Approval duration

1 year